Page last updated: 2024-08-24

triazoles and Mast-Cell Leukemia

triazoles has been researched along with Mast-Cell Leukemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acquaviva, J; Bear, MD; Bechtel, SA; Bernabe, LF; Gardner, HL; London, CA; Ogawa, LS; Proia, DA; Sequeira, M; Smith, DL	1
Arock, M; Blatt, K; Bradner, JE; Cerny-Reiterer, S; Eisenwort, G; Hadzijusufovic, E; Herrmann, H; Hoermann, G; Hoffmann, T; Horny, HP; Müllauer, L; Radia, D; Reiter, A; Sadovnik, I; Schwaab, J; Sperr, WR; Valent, P; Wedeh, G; Zuber, J	1
Barsoum, J; Bear, M; Du, Z; Foley, KP; Lin, TY; London, C; Ying, W	1

Trials

1 trial(s) available for triazoles and Mast-Cell Leukemia

Article	Year
Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 12-15, Volume: 24, Issue:24 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Dogs; HSP90 Heat-Shock Proteins; Leukemia, Mast-Cell; Mice; Oncogenes; Proteolysis; Proto-Oncogene Proteins c-kit; Treatment Outcome; Triazoles; Xenograft Model Antitumor Assays	2018

Article

Year

Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 12-15, Volume: 24, Issue:24

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Dogs; HSP90 Heat-Shock Proteins; Leukemia, Mast-Cell; Mice; Oncogenes; Proteolysis; Proto-Oncogene Proteins c-kit; Treatment Outcome; Triazoles; Xenograft Model Antitumor Assays

2018

Other Studies

2 other study(ies) available for triazoles and Mast-Cell Leukemia

Article	Year
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia. Leukemia, 2015, Volume: 29, Issue:11 Topics: Antigens, CD; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Leukemia, Mast-Cell; Nuclear Proteins; Proto-Oncogene Proteins c-kit; Receptors, Transferrin; Tetraspanin 30; Transcription Factors; Tretinoin; Triazoles	2015
The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors. Experimental hematology, 2008, Volume: 36, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; DNA Primers; Dog Diseases; Dogs; HSP90 Heat-Shock Proteins; Leukemia, Mast-Cell; Mastocytoma; Mice; Mice, SCID; Proto-Oncogene Proteins c-kit; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous; Triazoles	2008

Article

Year

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.

Leukemia, 2015, Volume: 29, Issue:11

Topics: Antigens, CD; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Leukemia, Mast-Cell; Nuclear Proteins; Proto-Oncogene Proteins c-kit; Receptors, Transferrin; Tetraspanin 30; Transcription Factors; Tretinoin; Triazoles

2015

The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors.

Experimental hematology, 2008, Volume: 36, Issue:10

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; DNA Primers; Dog Diseases; Dogs; HSP90 Heat-Shock Proteins; Leukemia, Mast-Cell; Mastocytoma; Mice; Mice, SCID; Proto-Oncogene Proteins c-kit; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous; Triazoles

2008